Long-term stabilization of recombinant human interferon α 2b in aqueous solution without serum albumin


Abstract:

The development of parenteral solution dosage forms of interferon α 2 (rhIFN-α2) without human albumin may significantly diminish the problem of forming highly immunogenic rhIFN-α2b aggregates and the potential risk of blood-transmitted diseases caused by infectious viruses and often living pathogens that may be present in the plasma. With this purpose, we evaluated the compatibility of type I borosilicate glass vials and chlorobutyl stoppers with rhIFN-α2b in an aqueous solution. At the same time, we carried out a targeted formulation screen at 37°C of single or combined (e.g. polysorbate 80, EDTA Na<inf>2</inf>, PEG 400) potentially stabilizing excipients. Quantified biochemical results from 12 independent batches of rhIFN-α2b in a polysorbate/benzyl alcohol-based vehicle formulated at pH 7.4 were all found within the limits established by the World Health Organization for this cytokine. Real-time storage data confirmed the excellent biochemical long-term (30 months) stability of rhIFN-α2b in this aqueous solution formulation. Analyses were performed at intervals throughout the time period using reverse-phase high-performance liquid chromatography, a sandwich-type enzyme-linked immunosorbent assay, and antiviral activity as stability-indicating assays. Furthermore, both the physical stability (color, odor, appearance, pH, and absence of particulate material) and the sterility of this formulation were maintained under the proposed shelf conditions. © 2003 Elsevier B.V. All rights reserved.

Año de publicación:

2003

Keywords:

  • Degradation pathway
  • Excipient
  • formulation
  • stability
  • INTERFERÓN

Fuente:

scopusscopus

Tipo de documento:

Article

Estado:

Acceso restringido

Áreas de conocimiento:

  • Farmacología
  • Farmacología
  • Solución acuosa

Áreas temáticas de Dewey:

  • Farmacología y terapéutica
  • Ingeniería química
  • Bioquímica
Procesado con IAProcesado con IA

Objetivos de Desarrollo Sostenible:

  • ODS 3: Salud y bienestar
  • ODS 16: Paz, justicia e instituciones sólidas
  • ODS 17: Alianzas para lograr los objetivos
Procesado con IAProcesado con IA